|
|
|
|
Infectious Retinitis: A Review
Stagno S, Reynolds DW, Amos CS, et al.Auditory and visual defects resulting from symptomatic and subclinical congenital cytomegaloviral and toxoplasma infections. Pediatrics. 1977;59:669-678. Conboy TJ, Pass RF, Stagno S, et al.
|
|
|
Cytomegalovirus Retinitis in a Monocular Patient
Management options were constrained by poor vision in the fellow eye.CHIRAG P. SHAH, MD, MPH JULIA A. HALLER, MD A 41-year-old female experienced blurred visual acuity in her right eye for several days, associated with fevers and...
|
|
|
Enzymatic treatment of retinitis pigmentosis
Title: United States Patent: 7,445,777 Inventors: Ammannati; Paola (56125 - Pisa, IT), Giordani; Roberto (56125 - Pisa, IT) Appl.No.: 10/530,067 Filed: October 1, 2002 PCT Filed: October 01, 2002 PCT No.: PCT/IT02/00624 371(c)(1),(2),(4)...
|
|
|
Second Sight Expands International Clinical Trial for Argus II RetinalImplant
Second Sight Medical Products, Inc., the leading developer of retinal prostheses for the blind, announced that it will increase patient enrollment for the ArgusTM II Retinal Implant study throughout clinical trials sites within Europe.The...
|
|
|
TI's bionic eye to go for clinical trials in India by 2009 end
India could be the next destination for clinical trials for the artificial retina referred to as the retinal prosthesis or bionic eye developed by Texas Instruments Incorporated (TI), a world leader in analog, signal processor and...
|
|
|
Massachusetts General Hospital: Gene therapy restores vision to mice with retinal degeneration
Gene therapy restores vision to mice with retinal degeneration (NewsRx.com) -- Massachusetts General Hospital (MGH) researchers have used gene therapy to restore useful vision to mice with degeneration of the light-sensing retinal rods and...
|
|
|
Texas Instruments Developer meet to showcase advanced medical technologies
Texas Instruments India will host the 11th annual TIDC (Texas Instruments Developer Conference) 2008 between November 5 and 6, 2008 in Bangalore.The pre-TIDC hands-on tutorials will also be held in Bangalore on November 3 and 4, 2008.
|
|
|
Management of Retinitis Pigmentosa
ELIOT L.BERSON, MD Retinitis pigmentosa (RP) has a prevalence of about 1 in 4000; an estimated 2 million people are affected worldwide. The condition is most often inherited by an autosomal dominant, autosomal recessive, or...
|
|
|
StemCells, Inc. announces preclinical results showing its proprietary human neural stem cells can prevent visi
PALO ALTO, Calif.- reported today that its proprietary HuCNS-SC(R) product candidate (purified human neural stem cells), when transplanted into a well-established animal model, can protect the retina from progressive degeneration.
|
|
|
Neurotech Announces the Opening of Its GMP Manufacturing Facility in Cumberland, Rhode Island
/PRNewswire/ -- Neurotech Pharmaceuticals, Inc., a privately-held biotechnology company focused on the development of sight-saving therapeutics for chronic retinal diseases, announced today the opening of its new 27,000 square-foot GMP...
|
|
|
QLT Announces the Initiation of a Phase I Trial of its Synthetic Retinoid Product
/PRNewswire-FirstCall/ - QLT Inc.announced today that it has initiated a Phase I safety study in healthy adults of QLT091001, an orally administered synthetic retinoid replacement therapy for 11-cis-retinal, which is a key biochemical...
|
|
|
Stem Cell Voice of India - a ray of hope for suffering people
Karan (Sonny) Goel, a young entrepreneur, who despite his visual disability, recently founded 'Stem Cell Voice of India', an NGO to make use of stem cell potential by integrating all the sectors related to this field like scientists, doctors...
|
|
|
Neurotech Granted Fast Track Designations from the FDA for NT-501 in Two Indications - Retinitis Pigmentosa an
/PRNewswire/ -- Neurotech Pharmaceuticals, Inc., a privately-held biotechnology company focused on the development of sight-saving therapeutics for chronic retinal diseases, announced today that the U.S.Food and Drug Administration (FDA)...
|
